A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma
- 1 August 1992
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 10 (3) , 225-230
- https://doi.org/10.1007/bf00877251
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Rationale for immunotherapy of renal cell carcinomaUrological Research, 1990
- INTERACTION OF FLUOROURACIL AND INTERFERON IN HUMAN COLON CANCER CELL-LINES - CYTOTOXIC AND CYTOKINETIC EFFECTS1990
- Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].1988
- Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.Journal of Clinical Oncology, 1985
- TREATMENT OF RENAL-CELL CARCINOMA WITH ALPHA-(HUMAN LEUKOCYTE) INTERFERON AND VINBLASTINE IN COMBINATION - A PHASE I-II TRIAL1985
- Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cellsBiochemical Journal, 1983
- Renal cell carcinoma: antitumor effects of leukocyte interferon.1983
- Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissuesCancer Letters, 1983
- Inhibition of Cell Division by InterferonsEuropean Journal of Biochemistry, 1981